Furthermore, NF-κB activity is frequently elevated in many tumor types, including leukemia, lymphoma, prostate cancer, breast cancer, colon cancer, melanoma, and head and neck cancer (Garg et al., 2003; Dolcet et al., 2005; Fan et al., 2013; Wu et al., 2017). Here, NFKB1 is linked to neoplasm.